CLP

DRUG3 trials

Sponsors

Sorbent Therapeutics

Conditions

Heart Failure

Phase 1

Evaluation of CLP With and Without Spironolactone in Heart Failure Patients With Chronic Kidney Disease

CompletedNCT01598740

Sorbent TherapeuticsHeart Failure

Start: 2012-06-30End: 2012-09-30Updated: 2013-07-19

Phase 2

Evaluation of CLP in Heart Failure Patients With Chronic Kidney Disease

CompletedNCT01265524

Sorbent TherapeuticsHeart Failure

Start: 2011-04-30Updated: 2013-03-13

Evaluation of Cross-Linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects

Sorbent TherapeuticsHeart Failure

Start: 2013-01-31End: 2014-06-30Target: 270Updated: 2014-03-05

Related Papers

A double-blind, randomized, parallel, placebo-controlled study examining the effect of cross-linked polyelectrolyte in heart failure patients with chronic kidney disease.

2012-05-2111 citations